Substance P and its inhibition in ocular inflammation

Fabio Bignami, Paolo Rama, Giulio Ferrari

Research output: Contribution to journalArticlepeer-review


Neuropeptides, and specifically Substance P (SP), can crucially contribute to the ocular inflammatory response. SP is an undecapeptide that is secreted from sensory nerve endings and from various immune cells during inflammation. SP modulates ocular inflammation through its binding with the high-affinity neurokinin-1 receptor (NK-1R). This receptor is expressed on nerves, immune cells, and epithelial cells. SP is a key mediator of neurogenic inflammation as it induces increased microvascular permeability, vasodilatation, plasma extravasation, and subsequent tissue edema. In addition, macrophages can release inflammatory mediators such as interleukins, chemokines, and growth factors in response to SP stimulation. Inhibition of SP activity, either through blockade of the neuropeptide release or the use of SP receptor antagonists, ameliorates ocular inflammation, it restores immune privilege and improves a number of clinical endpoints associated with inflammation, such as corneal opacity, ocular perforation, and angiogenesis. This review of the literature will summarize the role of SP in the ocular inflammatory response (with an emphasis on the ocular surface). In addition, it will review the therapeutic effects of SP blockade to control ocular inflammation (i) in animal models and (ii) in highly prevalent human diseases.

Original languageEnglish
Pages (from-to)1265-1274
Number of pages10
JournalCurrent Drug Targets
Issue number11
Publication statusPublished - Sep 1 2016


  • Corneal neovascularization
  • Neurogenic inflammation
  • Neuropeptide
  • Ocular inflammation
  • Substance p
  • Tachykinins

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry


Dive into the research topics of 'Substance P and its inhibition in ocular inflammation'. Together they form a unique fingerprint.

Cite this